Biological causes of immunogenic cancer cell death (ICD) and anti-tumor therapy; Combination of Oncolytic virus-based immunotherapy and CAR T-cell therapy for ICD induction

Biological causes of immunogenic cancer cell death (ICD) and anti-tumor therapy; Combination of Oncolytic virus-based immunotherapy and CAR T-cell therapy for ICD induction

Abstract Chimeric antigen receptor (CAR) T-cell therapy is a promising and rapidly expanding therapeutic option for a wide range of human malignancies. Despite the ongoing progress of CAR T-cell therapy in hematologic malignancies, the application of this therapeutic strategy in solid tumors has enc...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Amirhossein Mardi, Anastasia V. Shirokova, Rebar N. Mohammed, Ali Keshavarz, Angelina Olegovna Zekiy, Lakshmi Thangavelu, Talar Ahmad Merza Mohammad, Faroogh Marofi, Navid Shomali, Amir Zamani, Morteza Akbari
Materialtyp: Revisão
Språk:engelska
Publicerad: 2022
Länkar:https://doi.org/10.1186/s12935-022-02585-z
https://cancerci.biomedcentral.com/track/pdf/10.1186/s12935-022-02585-z
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Internet

https://doi.org/10.1186/s12935-022-02585-z
https://cancerci.biomedcentral.com/track/pdf/10.1186/s12935-022-02585-z

Liknande verk